A detailed history of Legal & General Group PLC transactions in Illumina, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 1,591,760 shares of ILMN stock, worth $215 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
1,591,760
Previous 1,591,760 -0.0%
Holding current value
$215 Million
Previous $208 Million -0.0%
% of portfolio
0.04%
Previous 0.04%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$105.28 - $135.9 $1.87 Million - $2.41 Million
17,766 Added 1.13%
1,591,760 $208 Million
Q2 2024

Aug 14, 2024

BUY
$101.05 - $133.57 $10.8 Million - $14.3 Million
107,258 Added 7.31%
1,573,994 $164 Million
Q1 2024

Jul 01, 2024

BUY
$127.73 - $147.2 $26.3 Million - $30.3 Million
205,787 Added 16.32%
1,466,736 $201 Million
Q1 2024

May 14, 2024

SELL
$127.73 - $147.2 $29.4 Million - $33.9 Million
-230,047 Reduced 15.43%
1,260,949 $173 Million
Q4 2023

Feb 15, 2024

BUY
$92.79 - $142.53 $14.2 Million - $21.8 Million
153,264 Added 11.46%
1,490,996 $208 Million
Q3 2023

Nov 14, 2023

SELL
$128.91 - $192.44 $1.13 Million - $1.69 Million
-8,772 Reduced 0.65%
1,337,732 $184 Million
Q2 2023

Aug 14, 2023

BUY
$183.43 - $232.67 $12 Million - $15.2 Million
65,186 Added 5.09%
1,346,504 $252 Million
Q1 2023

May 15, 2023

BUY
$193.75 - $232.55 $6.79 Million - $8.15 Million
35,029 Added 2.81%
1,281,318 $298 Million
Q4 2022

Feb 14, 2023

SELL
$187.24 - $242.74 $7.06 Million - $9.15 Million
-37,697 Reduced 2.94%
1,246,289 $252 Million
Q3 2022

Nov 14, 2022

SELL
$177.23 - $227.44 $2.42 Million - $3.11 Million
-13,664 Reduced 1.05%
1,283,986 $245 Million
Q2 2022

Aug 22, 2022

BUY
$181.58 - $368.0 $9.63 Million - $19.5 Million
53,053 Added 4.26%
1,297,650 $239 Million
Q1 2022

May 16, 2022

BUY
$303.87 - $423.8 $24.3 Million - $33.9 Million
80,060 Added 6.87%
1,244,597 $435 Million
Q4 2021

Feb 14, 2022

BUY
$347.28 - $421.83 $26.6 Million - $32.4 Million
76,719 Added 7.05%
1,164,537 $443 Million
Q3 2021

Nov 15, 2021

BUY
$405.61 - $524.84 $26.3 Million - $34 Million
64,874 Added 6.34%
1,087,818 $441 Million
Q2 2021

Aug 12, 2021

BUY
$372.84 - $481.5 $12.2 Million - $15.7 Million
32,705 Added 3.3%
1,022,944 $484 Million
Q1 2021

May 17, 2021

SELL
$361.28 - $504.76 $1.07 Million - $1.49 Million
-2,960 Reduced 0.3%
990,239 $380 Million
Q4 2020

Feb 12, 2021

SELL
$292.7 - $370.96 $609,108 - $771,967
-2,081 Reduced 0.21%
993,199 $367 Million
Q3 2020

Nov 13, 2020

BUY
$268.51 - $400.74 $8.34 Million - $12.5 Million
31,071 Added 3.22%
995,280 $308 Million
Q2 2020

Aug 14, 2020

BUY
$256.46 - $373.01 $827,339 - $1.2 Million
3,226 Added 0.34%
964,209 $357 Million
Q1 2020

May 14, 2020

BUY
$209.2 - $335.53 $10.5 Million - $16.9 Million
50,376 Added 5.53%
960,983 $265 Million
Q4 2019

Feb 13, 2020

BUY
$288.29 - $335.49 $8.38 Million - $9.75 Million
29,072 Added 3.3%
910,607 $302 Million
Q3 2019

Nov 13, 2019

BUY
$266.84 - $378.23 $671,369 - $951,626
2,516 Added 0.29%
881,535 $268 Million
Q2 2019

Aug 14, 2019

SELL
$300.59 - $368.15 $556,993 - $682,181
-1,853 Reduced 0.21%
879,019 $324 Million
Q1 2019

May 15, 2019

BUY
$272.57 - $321.18 $46.3 Million - $54.5 Million
169,794 Added 23.88%
880,872 $274 Million
Q4 2018

Feb 15, 2019

BUY
$272.46 - $366.54 $14.5 Million - $19.5 Million
53,304 Added 8.1%
711,078 $213 Million
Q3 2018

Nov 20, 2018

BUY
$279.04 - $367.06 $11.7 Million - $15.4 Million
41,978 Added 6.82%
657,774 $241 Million
Q2 2018

Aug 10, 2018

SELL
$228.17 - $292.07 $9.15 Million - $11.7 Million
-40,091 Reduced 6.11%
615,796 $172 Million
Q1 2018

May 17, 2018

SELL
$209.54 - $253.91 $2.89 Million - $3.5 Million
-13,783 Reduced 2.06%
655,887 $155 Million
Q4 2017

Feb 13, 2018

BUY
$202.23 - $230.03 $135 Million - $154 Million
669,670
669,670 $146 Million

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $21.3B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.